Roose K - Search Results

1

A20 (Tnfaip3) deficiency in myeloid cells protects against influenza A virus infection.

Maelfait J, Roose K, Bogaert P, Sze M, Saelens X, Pasparakis M, Carpentier I, van Loo G, Beyaert R. Maelfait J, et al. Among authors: roose k. PLoS Pathog. 2012;8(3):e1002570. doi: 10.1371/journal.ppat.1002570. Epub 2012 Mar 1. PLoS Pathog. 2012. PMID: 22396652 Free PMC article.

2

An influenza A vaccine based on tetrameric ectodomain of matrix protein 2.

De Filette M, Martens W, Roose K, Deroo T, Vervalle F, Bentahir M, Vandekerckhove J, Fiers W, Saelens X. De Filette M, et al. Among authors: roose k. J Biol Chem. 2008 Apr 25;283(17):11382-7. doi: 10.1074/jbc.M800650200. Epub 2008 Feb 5. J Biol Chem. 2008. PMID: 18252707 Free PMC article.

3

Pandemic preparedness: toward a universal influenza vaccine.

Roose K, Fiers W, Saelens X. Roose K, et al. Drug News Perspect. 2009 Mar;22(2):80-92. doi: 10.1358/dnp.2009.22.2.1334451. Drug News Perspect. 2009. PMID: 19330167 Free article. Review.

4

M2e-based universal influenza A vaccine.

Fiers W, De Filette M, El Bakkouri K, Schepens B, Roose K, Schotsaert M, Birkett A, Saelens X. Fiers W, et al. Among authors: roose k. Vaccine. 2009 Oct 23;27(45):6280-3. doi: 10.1016/j.vaccine.2009.07.007. Vaccine. 2009. PMID: 19840661 Review.

5

Antiserum against the conserved nine amino acid N-terminal peptide of influenza A virus matrix protein 2 is not immunoprotective.

De Filette M, Ysenbaert T, Roose K, Schotsaert M, Roels S, Goossens E, Schepens B, Fiers W, Saelens X. De Filette M, et al. Among authors: roose k. J Gen Virol. 2011 Feb;92(Pt 2):301-6. doi: 10.1099/vir.0.027086-0. Epub 2010 Oct 21. J Gen Virol. 2011. PMID: 20965983

6

Recombinant influenza virus carrying the respiratory syncytial virus (RSV) F85-93 CTL epitope reduces RSV replication in mice.

De Baets S, Schepens B, Sedeyn K, Schotsaert M, Roose K, Bogaert P, Fiers W, Saelens X. De Baets S, et al. Among authors: roose k. J Virol. 2013 Mar;87(6):3314-23. doi: 10.1128/JVI.03019-12. Epub 2013 Jan 9. J Virol. 2013. PMID: 23302879 Free PMC article.

7

Hepatitis B core-based virus-like particles to present heterologous epitopes.

Roose K, De Baets S, Schepens B, Saelens X. Roose K, et al. Expert Rev Vaccines. 2013 Feb;12(2):183-98. doi: 10.1586/erv.12.150. Expert Rev Vaccines. 2013. PMID: 23414409 Free article. Review.

8

M2e-displaying virus-like particles with associated RNA promote T helper 1 type adaptive immunity against influenza A.

Ibañez LI, Roose K, De Filette M, Schotsaert M, De Sloovere J, Roels S, Pollard C, Schepens B, Grooten J, Fiers W, Saelens X. Ibañez LI, et al. Among authors: roose k. PLoS One. 2013;8(3):e59081. doi: 10.1371/journal.pone.0059081. Epub 2013 Mar 18. PLoS One. 2013. PMID: 23527091 Free PMC article.

9

Single-domain antibodies targeting neuraminidase protect against an H5N1 influenza virus challenge.

Cardoso FM, Ibañez LI, Van den Hoecke S, De Baets S, Smet A, Roose K, Schepens B, Descamps FJ, Fiers W, Muyldermans S, Depicker A, Saelens X. Cardoso FM, et al. Among authors: roose k. J Virol. 2014 Aug;88(15):8278-96. doi: 10.1128/JVI.03178-13. Epub 2014 May 14. J Virol. 2014. PMID: 24829341 Free PMC article.

10

Influenza vaccines to control influenza-associated bacterial infection: where do we stand?

Christopoulou I, Roose K, Ibañez LI, Saelens X. Christopoulou I, et al. Among authors: roose k. Expert Rev Vaccines. 2015 Jan;14(1):55-67. doi: 10.1586/14760584.2015.957191. Epub 2014 Sep 11. Expert Rev Vaccines. 2015. PMID: 25209381 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters